Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Fiscus

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|April 7, 1999
Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, BrazilC D Pilcher, M D Perkins, S A Fiscus, et al.
The Journal of Infectious Diseases|February 1, 1995
Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trialS A Fiscus, V DeGruttola, P Gupta, et al.
AIDS (London, England)|April 24, 2001
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric modelH Chakraborty, P K Sen, R W Helms, et al.
The Journal of Infectious Diseases|April 27, 2000
The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850)J J Eron, L M Smeaton, S A Fiscus, et al.
Lancet (London, England)|June 28, 1997
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research GroupM S Cohen, I F Hoffman, R A Royce, et al.
Journal of Virology|September 12, 2000
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semenL H Ping, M S Cohen, I Hoffman, et al.
AIDS (London, England)|June 16, 2001
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public healthC D Pilcher, D C Shugars, S A Fiscus, et al.
Journal of Clinical Microbiology|September 1, 1996
Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials GroupW A Scott, D Brambilla, E Siwak, et al.
Annals of Internal Medicine|December 4, 2001
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320L M Demeter, M D Hughes, R W Coombs, et al.
The Journal of Infectious Diseases|June 2, 1998
High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan AfricaJ R Dyer, P Kazembe, P L Vernazza, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|April 7, 1999
Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, BrazilC D Pilcher, M D Perkins, S A Fiscus, et al.
The Journal of Infectious Diseases|February 1, 1995
Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trialS A Fiscus, V DeGruttola, P Gupta, et al.
AIDS (London, England)|April 24, 2001
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric modelH Chakraborty, P K Sen, R W Helms, et al.
The Journal of Infectious Diseases|April 27, 2000
The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850)J J Eron, L M Smeaton, S A Fiscus, et al.
Lancet (London, England)|June 28, 1997
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research GroupM S Cohen, I F Hoffman, R A Royce, et al.
Journal of Virology|September 12, 2000
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semenL H Ping, M S Cohen, I Hoffman, et al.
AIDS (London, England)|June 16, 2001
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public healthC D Pilcher, D C Shugars, S A Fiscus, et al.
Journal of Clinical Microbiology|September 1, 1996
Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials GroupW A Scott, D Brambilla, E Siwak, et al.
Annals of Internal Medicine|December 4, 2001
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320L M Demeter, M D Hughes, R W Coombs, et al.
The Journal of Infectious Diseases|June 2, 1998
High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan AfricaJ R Dyer, P Kazembe, P L Vernazza, et al.
Pageof 8